Immunogenicity of two modern tissue culture rabies vaccines in pre-exposure prophylaxis

Human Vaccines

Volumn 3, Issue 5, 2007, Pages 183-186

  Kulkarni, P S ^a   Raut, Sidram K ^a   Jadhav, Suresh S ^a   Kapre, Subhash V ^a   Deuskar, Nileema ^a  

^a Serum Institute of India Ltd   (India)

Author keywords

CEC; HDC; Immunogenicity; Pre exposure prophylaxis; Rabies vaccine

Indexed keywords

ANTIBODY; DIPLOID CELL VACCINE; RABIES VACCINE; RABIVAX; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; HUMAN; IMMUNOGENICITY; INDIA; INFECTION PREVENTION; MALE; OCCUPATIONAL EXPOSURE; PHASE 4 CLINICAL TRIAL; RABIES; RETROSPECTIVE STUDY; TISSUE CULTURE;

EID: 35349030250     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.3.5.4360     Document Type: Article

References (22)

1. Warrell MJ, Warrell DA. Rabies and other lyssavirus diseases. Lancet 2004; 363:959-69.
2. Plotkin SA. Rabies. Clin Infect Dis 2000; 30:4-12.
3. World Health Organization. World survey for rabies No. 35 for the year 1999. Geneva: World Health Organization 2002, (http://www.who.int/emc-documents/ rabies/whocdscs-reph200210.html).
4. Rotz LD, Hensley JA, Rupprecht CE, Childs JE. Large-scale human exposures to rabid or presumed rabid animals in the United States: 22 cases (1990-1996). J Am Vet Med Assoc 1998; 212:1198-200.
5. Krebs JW, Long-Marin SC, Childs JE. Causes, costs, and estimates of rabies post exposure prophylaxis treatments in the United States. J Public Health Management Practices 1998; 4:56-62.
6. Moran GJ, Talan DA, Mower W, Newdow M, Ong S, Nakase JY, Pinner RW, Childs JE. Appropriateness of rabies post exposure prophylaxis treatment for animal exposures. JAMA 2000; 284:1001-7.
7. Human rabies prevention - United States. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recommendation Report, 1999:48:1-21.
8. Plotkin SA. Vaccine production in human diploid cell strains. Am J Epidemiol 1971; 94:303-6.
9. Rabies vaccines. WHO position paper. Wkly Epidemiol Rec 2002:77:109-20.
10. Bahmanyar M. Results of rabies post-exposure treatment with antirabies serum and the human diploid cell vaccine in Iran. Dev Biol Stand 1978; 40:163-5.
11. Bijok U, Vodopija I, Smerdel S, Thongcharoen P, Nicholson K, Dietrich M, Gonzalez de Cosio A. Purified chick embryo cell (PCEC) rabies vaccine for human use: Clinical trials. Behring Institute Mitteilungen 1984; 76:155-64.
12. Briggs DJ, Dreesen DW, Nicolay U, Chin JE, Davis R, Gordon C, Banzhoff A. Purified chick embryo cell culture rabies vaccine: Interchangeability with human diploid cell culture rabies vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons. Vaccine 2000; 19:1055-60.
13. Bhardwaj M, Bhattacharya D, Chabra M, Icchpujani RL. Immunogenicity of purified chick embryo cell anti-rabies vaccine in post-exposure treatment of animal bite cases. J Commun Dis 2002; 34:40-2.
14. Deshpande AK, Londhe VA, Akarte S, Briggs D. Comparative evaluation of immunogenicity, reactogenicity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine. J Assoc Physicians of India 2003; 51:655-8.
15. Sehgal S, Bhattacharya D, Bhardwaj M. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population. J Commun Dis 1995; 27:36-43.
16. Wilde H, Sirikawin S, Sabcharoen A, Kingnate D, Tantawichien T, Harischandra PA, Chaiyabutr A, De Silva DG, Fernando L, Liyanagel JB, Sitprijal V. Failure of post exposure treatment of rabies in children. Clin Infect Dis 1996; 22:228-32.
17. Hemachudha T, Mitrabhakdi E, Wilde H, Vejabhuti A, Siripataravanit S, Kingnate D. Additional reports of failure to respond to treatment after rabies exposure in Thailand. Clin Infect Dis 1999; 28:143-4.
18. John BM, Patnaik SK. Fatal rabies despite appropriate post-exposure prophylaxis. Indian Pediatrics 2005; 42:839-40.
19. Data on file.
20. Product literature: Bio-Rad Platelia® Rabies Kit 72200. For the detection and assay of rabies virus anti-glycoprotein antibodies. 2000, (Code:863112).
21. Lau C, Sisson J. The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic. J Travel Med 2002; 9:285-8.
22. Mims India Monthly Index of Medical Specialities 2006; 3:231.